Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Purchase individual online access for 1 year to this journal.
Price: EUR 185.00Authors: Ehrly, A.M.
Article Type: Research Article
Keywords: In vivo-ridification of erythrocytes, microcirculation, hemorheology
DOI: 10.3233/CH-1990-10610
Citation: Clinical Hemorheology and Microcirculation, vol. 10, no. 6, pp. 625-635, 1990
Authors: Heini, H. | Pfitzner, D. | Keuchel, M. | Ebel, H. | Lange, H. | Wichert, P.v.
Article Type: Research Article
Abstract: We compared the effect of a constant versus a decreasing ultrafiltration rate during hemodialysis on plasma viscosity, erythrocyte aggregation (hematocrit adjusted to 40%) and blood viscosity (hematocrit 40%; shear rates 23.04, 46.08, 115.2 and 230.4/″) in 5 woman and 10 men with chronic renal failure due to different origins, mean age 67.3 ± 6.7 years. Measurements were done before and after dialysis. The regimen with a constant ultrafiltration rate increased plasma viscosity (1.36 ± 0.09 to 1.48 ± 0.16 cPs, P < 0.01) and blood viscosity at high shear (230.4/″; 3.51 ± 0.34 to 3.91 ± 0.73 cPs, p < …0.05), the other parameters remained unchanged. There was a good correlation to the change in protein concentration before and after dialysis due to hemoconcentration (6.61 ± 0.54 to 7.51 ± 1.02 mg%, r = 0.85, p < 0.01). The regimen with a decreasing ultrafiltration rate caused no significant change in the rheological parameters. The weight loss was comparable in both regimens. We conclude that a decreasing ultrafiltration rate during hemodialysis is associated with less disturbances of rheology. Show more
Keywords: hemodialysis, blood rheology, plasma rheology
DOI: 10.3233/CH-1990-10611
Citation: Clinical Hemorheology and Microcirculation, vol. 10, no. 6, pp. 637-644, 1990
Authors: Baumler, H. | Distler, B. | Scherf, H.-P. | Mockel, C. | Miller, H. | Lerche, D. | Papies, B.
Article Type: Research Article
Abstract: The possible influence of dialysis on the metabolism of reactive oxygen species as well as the flow properties of blood were investigated. 22 patients suffering from chronical renal failure were hemodialysed every second day. 11 of them were additional treated with ultraviolet irradiated own blood. The concentration of thiobarbituric acid reactive substances (TBARS) was normal (3.6±0.8 nmol) before hemodialysis and rose during hemodialysis up to 4.6±1.0 nmol). This increase of TBARS was no longer seen in the uv treated patients. The parameters of RBC aggregation were neither significantly different in the two patient groups before the treatment nor different in …comparison with healthy persons. The orientability of RBC of the patient groups was significantly reduced in comparison with that of the healthy group at the beginning of investigation and was significantly improved after uv treatment. The retransfusion of uv irradiated own blood seems to result in a decreased oxidative stress. Show more
Keywords: red blood cell, TBARS, lipid peroxiclation, oxygen radicals, RBC aggregation, RBC deformability
DOI: 10.3233/CH-1990-10612
Citation: Clinical Hemorheology and Microcirculation, vol. 10, no. 6, pp. 645-652, 1990
Authors: Paulitschke, M. | Meier, W. | Lerche, D. | Zoellner, K. | Schmidt, G.
Article Type: Research Article
Abstract: The deformability of RBC in uremic hemodialysed children was determined by two different micropipette techniques (apparent elastic shear modulus of RBC membrane µ; entry time te and amplitude A) in dependence on the period of rhEPO administration. At the outset, mean hematocrit of the 10 children enclosed in the study was 0.20 +/− 0.02, mean predialysis levels of serum creatinine and urea nitrogen were (919 +/− 163)µMol/l and (24.3 +/− 3.0)mMol/l, respectively. Dialysis was performed with hollow fiber dialyzer three times a week for 4 hours each. Mean µ, te and A in children with end-stage renal disease …were found to be elevated by 126, 54 and 65 %, respectively, above corresponding mean values of the healthy reference group. Under the therapy with rhEPO mean values of µ, te and A were already significantly decreased by 67, 35 and 34 %, respectively, within the correction period (rhEPO dose: 100 IU/kg/week). In the maintenance period of rhEPO therapy (Hct = 0.30 +/− 0.03) the mean values of deformability parameters reached those of the healthy reference group. Mean cell volume of uremic erythrocytes rose significantly under rhEPO administration. This study showed that under rhEPO therapy apart from the desired correction of anemia of end-stage renal disease the impaired rheological properties of uremic RBC will also be normalised. This findings underline that the impaired RBC deformability in hemodialysed uremic patients cannot be attributed to “uremic toxines” alone. Show more
Keywords: uremia, erythropoietin, RBC membrane, shear elastic modulus, deformability/passage analyzer, cell volume
DOI: 10.3233/CH-1990-10613
Citation: Clinical Hemorheology and Microcirculation, vol. 10, no. 6, pp. 653-664, 1990
Authors: Mineshita, Takeshi
Article Type: Abstract
DOI: 10.3233/CH-1990-10614
Citation: Clinical Hemorheology and Microcirculation, vol. 10, no. 6, pp. 665-670, 1990
Article Type: Announcement
DOI: 10.3233/CH-1990-10615
Citation: Clinical Hemorheology and Microcirculation, vol. 10, no. 6, pp. 671-672, 1990
Article Type: Other
DOI: 10.3233/CH-1990-10616
Citation: Clinical Hemorheology and Microcirculation, vol. 10, no. 6, pp. 673-675, 1990
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]